Connect with us
[ad_1] Pfizer Inc. Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide....
[ad_1] China has turned a corner in its zero-Covid policy, lifting quarantines for foreign travelers from early next year, but that has come with cost as...
[ad_1] COVID-19 cases are once again rising in the U.S., but how prepared are we for the next pandemic? That’s a question worth asking. The $1.7...
[ad_1] A growing chorus of voices is questioning why there is no concerted effort to persuade Americans to wear face masks in public settings again as...
[ad_1] WSJ News Exclusive Business U.S. biotechnology company was the last of three suitors standing in an auction for Horizon [ad_2] Source link
[ad_1] Omicron subvariants continued to account for more new cases of COVID-19 in the U.S. in the latest week than did BA.5, according to the latest...
[ad_1] What worked well during the years-long bull market through 2021 — a focus on growth, regardless of price — has ground to a halt this...
[ad_1] The Food and Drug Administration on Thursday authorized the bivalent COVID-19 boosters made by Moderna Inc. MRNA, +3.18% and BioNTech SE BNTX, +5.64% /Pfizer Inc....
[ad_1] The head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus...
[ad_1] Widespread protests across China over the government’s zero-COVID policy dominated pandemic headlines Monday, with Anthony Fauci, President Joe Biden’s chief medical adviser, weighing in with...
[ad_1] More than 253,000 coronavirus cases have been found in China in the past three weeks and the daily average is rising, the government said Tuesday,...
[ad_1] As we head into the third winter of the pandemic, only about 13% of American adults — less than 11% of Americans overall — have...
[ad_1] A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and...
[ad_1] The head of the World Health Organization said a close to 90% decline in COVID deaths globally compared to nine months ago is “cause for...
[ad_1] China’s strict zero-COVID policy was making headlines Monday after Apple and iPhone manufacturer Foxconn said over the weekend that restrictions are crimping production and will...
[ad_1] First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher”...
[ad_1] Hospitalizations are rising again in New York City with the spread of new COVID-19 subvariants that are better at evading immunity. Cases of flu and...
[ad_1] The omicron sublineages named BQ.1 and BQ.1.1 continued to spread in the U.S. in the week through Oct. 29, accounting for 27.1% of new cases...
[ad_1] The Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that...
[ad_1] Pfizer Inc. PFE, +4.17% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.14% for $110 to $130...